The molecular testing (Oncomine Focus Assay) of the tumour cells from the pleural effusion showed persistent EGFR p.L858R and HER2 p.S310F mutations, but no ROS1 fusion transcripts. The gene discussed is ERBB2; the disease is neoplasm.